Celcuity Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

Celcuity Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. 1 Celcuity’s Gedatolisib Combination Regimens Doubled the Likelihood of Survival without Disease Progression or Death Compared to Alpelisib plus Fulvestrant in the PIK3CA Mutant Cohort of the Pivotal Phase 3 VIKTORIA-1 Trial in Patients with HR+/HER2- Advanced Breast Cancer ● Gedatolisib plus fulvestrant and palbociclib (the “gedatolisib-triplet&…